CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 125 filers reported holding CYTOKINETICS INC in Q2 2018. The put-call ratio across all filers is 0.22 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $22,292,735 | -11.4% | 756,712 | -1.9% | 0.01% | -14.3% |
| Q2 2023 | $25,152,564 | -1.1% | 771,078 | +6.7% | 0.01% | -12.5% |
| Q1 2023 | $25,431,144 | -23.6% | 722,681 | -0.5% | 0.01% | -27.3% |
| Q4 2022 | $33,269,077 | -2.6% | 726,082 | +3.0% | 0.01% | -8.3% |
| Q3 2022 | $34,168,000 | +43.3% | 705,212 | +16.2% | 0.01% | +50.0% |
| Q2 2022 | $23,849,000 | +7.9% | 606,995 | +1.1% | 0.01% | +14.3% |
| Q1 2022 | $22,104,000 | -17.1% | 600,492 | +2.7% | 0.01% | -12.5% |
| Q4 2021 | $26,649,000 | +21.9% | 584,666 | -4.4% | 0.01% | +14.3% |
| Q3 2021 | $21,857,000 | +116.0% | 611,533 | +19.6% | 0.01% | +133.3% |
| Q2 2021 | $10,119,000 | -8.1% | 511,304 | +8.0% | 0.00% | -25.0% |
| Q1 2021 | $11,015,000 | +15.7% | 473,519 | +3.3% | 0.00% | 0.0% |
| Q4 2020 | $9,522,000 | -2.0% | 458,182 | +2.1% | 0.00% | 0.0% |
| Q3 2020 | $9,718,000 | +6.0% | 448,851 | +15.4% | 0.00% | 0.0% |
| Q2 2020 | $9,167,000 | +111.5% | 388,889 | +5.8% | 0.00% | +33.3% |
| Q1 2020 | $4,334,000 | +13.9% | 367,535 | +2.5% | 0.00% | +50.0% |
| Q4 2019 | $3,804,000 | -5.0% | 358,522 | +1.8% | 0.00% | 0.0% |
| Q3 2019 | $4,006,000 | +7.9% | 352,021 | +6.7% | 0.00% | 0.0% |
| Q2 2019 | $3,711,000 | +57.5% | 329,825 | +13.3% | 0.00% | 0.0% |
| Q1 2019 | $2,356,000 | +30.9% | 291,219 | +2.3% | 0.00% | +100.0% |
| Q4 2018 | $1,800,000 | -37.1% | 284,755 | -2.0% | 0.00% | -50.0% |
| Q3 2018 | $2,862,000 | +36.9% | 290,494 | +15.4% | 0.00% | 0.0% |
| Q2 2018 | $2,090,000 | +28.4% | 251,805 | +11.4% | 0.00% | +100.0% |
| Q1 2018 | $1,628,000 | -18.8% | 225,992 | -8.1% | 0.00% | -50.0% |
| Q4 2017 | $2,004,000 | -54.4% | 245,793 | -19.0% | 0.00% | -50.0% |
| Q3 2017 | $4,399,000 | +29.7% | 303,347 | +8.3% | 0.00% | +33.3% |
| Q2 2017 | $3,391,000 | +65.8% | 280,205 | +76.1% | 0.00% | +50.0% |
| Q1 2017 | $2,045,000 | +32.0% | 159,096 | +24.8% | 0.00% | 0.0% |
| Q4 2016 | $1,549,000 | +40.3% | 127,442 | +6.0% | 0.00% | +100.0% |
| Q3 2016 | $1,104,000 | +103.7% | 120,204 | +110.5% | 0.00% | 0.0% |
| Q2 2016 | $542,000 | +34.5% | 57,100 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $403,000 | -32.6% | 57,100 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $598,000 | +94.2% | 57,100 | +24.4% | 0.00% | – |
| Q3 2015 | $308,000 | -0.3% | 45,900 | 0.0% | 0.00% | – |
| Q2 2015 | $309,000 | -1.0% | 45,900 | 0.0% | 0.00% | – |
| Q1 2015 | $312,000 | -15.2% | 45,900 | 0.0% | 0.00% | -100.0% |
| Q4 2014 | $368,000 | +127.2% | 45,900 | 0.0% | 0.00% | – |
| Q3 2014 | $162,000 | -26.4% | 45,900 | 0.0% | 0.00% | – |
| Q2 2014 | $220,000 | -49.7% | 45,900 | 0.0% | 0.00% | -100.0% |
| Q1 2014 | $437,000 | +90.0% | 45,900 | +30.0% | 0.00% | – |
| Q4 2013 | $230,000 | -13.2% | 35,300 | 0.0% | 0.00% | -100.0% |
| Q3 2013 | $265,000 | – | 35,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 223,382 | $6,580,834 | 7.72% |
| Finepoint Capital LP | 431,693 | $12,717,676 | 6.33% |
| Saturn V Capital Management LP | 495,168 | $14,587,649 | 6.11% |
| Logos Global Management LP | 1,250,000 | $36,825,000 | 4.91% |
| DAFNA Capital Management LLC | 479,538 | $14,127,189 | 4.39% |
| PFM Health Sciences, LP | 2,399,545 | $70,690,596 | 3.33% |
| Boxer Capital, LLC | 2,100,000 | $61,866,000 | 3.29% |
| Integral Health Asset Management, LLC | 800,000 | $23,568,000 | 3.26% |
| GREAT POINT PARTNERS LLC | 600,000 | $17,676,000 | 3.22% |
| Nicholas Investment Partners, LP | 942,137 | $27,755,356 | 2.07% |